No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

byKathleen Lau

January 7, 2021

in StudyGraphics

RELATED REPORTS

AstraZeneca’s Imfinzi shows positive results in phase 3 trial for treatment of limited-stage small cell lung cancer

#VisualAbstract: Cadonilimab Plus Chemotherapy Improves Survival in Recurrent or Metastatic Cervical Cancer

GPT-4 performing with superior scores on medical oncology examination questions

Perioperative changes of response to antiplatelet medication in vascular surgery patients

RelatedReports

Dacomitinib may be effective in EGFR-associated lung cancer

Pharma

AstraZeneca’s Imfinzi shows positive results in phase 3 trial for treatment of limited-stage small cell lung cancer

December 30, 2024

StudyGraphics

#VisualAbstract: Cadonilimab Plus Chemotherapy Improves Survival in Recurrent or Metastatic Cervical Cancer

December 19, 2024

Natural language processing may automate data extraction from radiologic reports

Oncology

GPT-4 performing with superior scores on medical oncology examination questions

December 17, 2024

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Addition of pembrolizumab to chemotherapy improves early-stage triple-negative breast cancer survival

December 16, 2024

#VisualAbstract: Total body skin examinations may aid in the detection of incidental skin cancers in patients with suspicious lesions

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

Glioblastoma phenotypes identified on MRI predict molecular behavior

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result